Literature DB >> 9080221

Heterogeneity of follicle stimulating hormone: control and physiological function.

S C Chappel1.   

Abstract

The existence of a heterogeneous population of follicle stimulating hormone (FSH) was described many years ago. Other pituitary glycoproteins, such as thyroid stimulating hormone (TSH) and luteinizing hormone (LH) as well as placental human chorionic gonadotrophin (HCG) also exhibit heterogeneity. Because FSH plays a significant role in a variety of ovarian activities such as follicular maturation, selection of the dominant follicle and ovulation, the possible role of subpopulations of FSH with distinct physicochemical characteristics is of great interest. After a great deal of investigation, the physiological significance of this biochemical phenomenon has yet to be fully understood. Investigators have employed immunoassays, in-vitro bioassays and radioreceptor assays to study the biological activity of the individual isoforms of FSH. As more information has accumulated, it has become clear that some of the initial assumptions used to interpret data may be incorrect. This review is provided to update the reader with available information on the topic as it relates to FSH and to point out issues that require re-evaluation in this area.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9080221     DOI: 10.1093/humupd/1.5.479

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  5 in total

1.  The Asn680Ser polymorphism of the follicle stimulating hormone receptor gene and ovarian cancer risk: a meta-analysis.

Authors:  Xue Qin; Liping Ma; Shi Yang; Jianyang Zhao; Siyuan Chen; Yantong Xie; Jian Wang; Taijie Li; Yu He; Qiliu Peng; Yan Deng; Shan Li; Aiping Qin
Journal:  J Assist Reprod Genet       Date:  2014-06       Impact factor: 3.412

2.  Effect of Follicle Stimulating Hormone Receptor Gene Polymorphisms in Cervical Cancer Risk.

Authors:  Sabrina Zidi; Mouna Stayoussef; Bano L Alsaleh; Ezzedine Gazouani; Amel Mezlini; Bashayer H Ebrahim; Besma Yacoubi-Loueslati; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2016-11-14       Impact factor: 3.201

3.  Reduced in vitro fertilization of human oocytes correlates with raised circulating FSH levels during ovarian stimulation in normogonadotropic women downregulated with GnRH-analogues.

Authors:  C Y Andersen; L G Westergaard; A G Byskov; K Erb
Journal:  J Assist Reprod Genet       Date:  1997-11       Impact factor: 3.412

4.  The practical implications of a raised serum FSH and age on the risk of IVF treatment cancellation due to a poor ovarian response.

Authors:  Valentine A Akande; Stephen D Keay; Linda P Hunt; Rajneesh S Mathur; Julian M Jenkins; David J Cahill
Journal:  J Assist Reprod Genet       Date:  2004-07       Impact factor: 3.412

5.  Recombinant follitropin alfa/lutropin alfa in fertility treatment.

Authors:  Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Biologics       Date:  2010-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.